Mechanisms and functional significance of tumour-induced dendritic-cell defects
- PMID: 15573129
- DOI: 10.1038/nri1498
Mechanisms and functional significance of tumour-induced dendritic-cell defects
Abstract
The failure of the immune system to provide protection against tumour cells is an important immunological problem. It is now evident that inadequate function of the host immune system is one of the main mechanisms by which tumours escape from immune control, as well as an important factor that limits the success of cancer immunotherapy. In recent years, it has become increasingly clear that defects in dendritic cells have a crucial role in non-responsiveness to tumours. This article focuses on the functional consequences and recently described mechanisms of the dendritic-cell defects in cancer.
Similar articles
-
Immunosuppressive networks in the tumour environment and their effect in dendritic cells.Biochim Biophys Acta. 2009 Jan;1795(1):16-24. doi: 10.1016/j.bbcan.2008.07.001. Epub 2008 Jul 15. Biochim Biophys Acta. 2009. Retraction in: Biochim Biophys Acta. 2013 Apr;1835(2):259. PMID: 18675885 Retracted. Review.
-
Dendritic cells as therapeutic vaccines against cancer.Nat Rev Immunol. 2005 Apr;5(4):296-306. doi: 10.1038/nri1592. Nat Rev Immunol. 2005. PMID: 15803149 Review.
-
Tumour-released exosomes and their implications in cancer immunity.Cell Death Differ. 2008 Jan;15(1):80-8. doi: 10.1038/sj.cdd.4402237. Epub 2007 Oct 12. Cell Death Differ. 2008. PMID: 17932500 Review.
-
Myeloid dendritic cell lectins and their role in immune responses.Curr Opin Investig Drugs. 2007 Nov;8(11):910-20. Curr Opin Investig Drugs. 2007. PMID: 17979024 Review.
-
Interplay of pathogens, cytokines and other stress signals in the regulation of dendritic cell function.Cytokine Growth Factor Rev. 2007 Feb-Apr;18(1-2):5-17. doi: 10.1016/j.cytogfr.2007.01.002. Epub 2007 Feb 26. Cytokine Growth Factor Rev. 2007. PMID: 17321783 Review.
Cited by
-
Altered heme-mediated modulation of dendritic cell function in sickle cell alloimmunization.Haematologica. 2016 Sep;101(9):1028-38. doi: 10.3324/haematol.2016.147181. Epub 2016 May 26. Haematologica. 2016. PMID: 27229712 Free PMC article.
-
Exosomal Communication Between the Tumor Microenvironment and Innate Immunity and Its Therapeutic Application.Immune Netw. 2022 Sep 26;22(5):e38. doi: 10.4110/in.2022.22.e38. eCollection 2022 Oct. Immune Netw. 2022. PMID: 36381957 Free PMC article. Review.
-
Tumour tissue microenvironment can inhibit dendritic cell maturation in colorectal cancer.PLoS One. 2011;6(11):e27944. doi: 10.1371/journal.pone.0027944. Epub 2011 Nov 18. PLoS One. 2011. PMID: 22125641 Free PMC article.
-
Cancer Cell Metabolism Bolsters Immunotherapy Resistance by Promoting an Immunosuppressive Tumor Microenvironment.Front Oncol. 2020 Jul 22;10:1197. doi: 10.3389/fonc.2020.01197. eCollection 2020. Front Oncol. 2020. PMID: 32775303 Free PMC article. Review.
-
The chemotherapeutic agent topotecan differentially modulates the phenotype and function of dendritic cells.Cancer Immunol Immunother. 2013 Aug;62(8):1315-26. doi: 10.1007/s00262-013-1431-9. Epub 2013 May 11. Cancer Immunol Immunother. 2013. PMID: 23666509 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical